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timate coronary physiology across intermediate stenosis, demon-
strating signiﬁcant association of blood DIB with FFR and iFR even in
relatively small MLA lesions. Further investigation is warranted to
conﬁrm the potential utility of RF-IVUS for hybrid (both anatomic and
functional) assessment of coronary artery disease, which may be
helpful for time and cost-effective resource utilization.
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BACKGROUND To determine the speciﬁc cause of death and their
potential inﬂuencing factors in patients with complex coronary artery
disease who underwent percutaneous coronary intervention (PCI) or
coronary artery bypass grafting (CABG) in the SYNTAX randomized
trial and nested registries.
METHODS An independent Clinical Events Committee consisting of
expert physicians blinded to the study treatment, sub-classiﬁed cau-
ses of death in cardiovascular (cardiac and vascular), non-cardiovas-
cular and undetermined according to the trial protocol. Cardiac deaths
were classiﬁed as sudden cardiac, myocardial infarction (MI)-related
and other cardiac deaths. Multivariate models were constructed to
identify independent predictors of all-cause and cardiac death after
PCI and CABG.
RESULTS In the randomized cohort, during 5-year follow-up, there
were 123 deaths after PCI and 97 deaths after CABG. After PCI, the
majority of deaths were cardiovascular (67.5%) and as a result of MI
(29.3%), whereas after CABG 49.4% of deaths were cardiovascular
with the largest cause being heart failure, arrhythmia or other
causes (24.6%). The cumulative incidence rates of all-cause death
were not signiﬁcantly different between CABG and PCI (11.4 vs.
13.9%, respectively; P¼0.10), while there were signiﬁcant differ-
ences in terms of cardiovascular (5.8 vs. 9.6%, respectively;
P¼0.008) and cardiac (5.3 vs. 9.0%, respectively; P¼0.003) death,
caused primarily by a reduction in MI-related death with CABG as
compared with PCI (0.4 vs. 4.1%, respectively; P<0.0001). The
difference in MI-related death was seen largely in patients with
diabetes, three-vessel disease, or high SYNTAX scores. Independent
predictors of all-cause and cardiac death consisted of baseline,
procedural and post-procedural variables, with important predictorsbeing discharge medication use and adverse events during follow-
up. Results for the nested registries were similar, although the
death rate in the PCI registry was higher and more often the result
of non-cardiovascular causes.
CONCLUSIONS The rate of all-cause death at 5 years was not signiﬁ-
cantly different between PCI and CABG. However, CABG in compari-
son with PCI was associated with a signiﬁcantly reduced rate of MI-
related death, which was the leading cause of death after PCI,
particularly in patients with complex disease and in the presence of
diabetes.
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BACKGROUND In the past two decades, signiﬁcant advances have
occurred in the management of coronary artery disease. It is un-
clear whether increased options for treatment, improved technology
and expanded available evidence have translated into nationwide
changes in comorbidity proﬁles and outcomes of patients present-
ing for PCI.
METHODS 3,387,976 Medicare beneﬁciaries >¼ 65 yrs of age who
underwent PCI from 1/2000 -11/2012 were included. Comorbidities
were determined using ICD-9-CM diagnostic codes from any hospi-
talization within 1 yr prior to index admission. Trends in patient
characteristics and hospital outcomes were assessed with Cochran-
Armitage trend tests. Long-term survival was examined with Kaplan-
Meier survival curves.
RESULTS From 2000 through 2006, the number of patients un-
dergoing PCI increased from 246,528 to 318, 622, and then
decreased to 161,667 in 2012 (11 months of data). There was a sig-
niﬁcant increase over time in the incidence of all comorbidities
examined, including HTN, diabetes, PVD, history of stroke or TIA,
heart failure, COPD, renal failure and atrial ﬁbrillation. The number
of patients presenting with acute MI increased from 26.9% in 2000
to 45.8% in 2012. Overall, 43.1% of the PCI admissions were elec-
tive, 38.3% were urgent and 18.6% were emergent. Angioplasty was
performed in 9.6%, and PCI with stent placement in 90.4%. The
use of bare metal stents declined from 85.7% in 2000 to 23.5% in
2012, with a corresponding increase in the use of drug-eluting
stents (DES) (70.3% in 2012). The use of DES peaked in 2005 at
84.1%. Hospital mortality increased from 2.1% in 2000 to 3.1% in
2012, despite reaching a nadir of 1.8% from 2004-2006. Hospital
mortality was 1% for elective, 2.1% for urgent and 4.5% for emer-
gent admissions. The biggest increase in mortality over time was
seen for elective admissions from 0.8% in 2000 to 3.4% in 2012.
Compared to year 2000, adjusted hospital mortality odds ratio was
1.42 in 2012 (95% CI 1.36 – 1.48), signifying 42% increase likelihood
of death with PCI during the study period after accounting for
differences in baseline characteristics. Overall survival was 93% at 6
months, 90% at 1 year, 80% at 3 years and 69% at 5 years. From
2000 through 2006, 5- year survival remained at 70%, and subse-
quently modestly declined to 66% for 2009.
Trends in baseline characteristics and outcomes of Medicare beneﬁciaries who underwent PCI from
1/2000-11/2012
Overall 2000 2002 2004 2006 2008 2010 2012
number 3387976 246528 293391 332988 318622 243418 204409 161667
median age(years) 75 75 75 75 75 75 75 75
female (%) 42.1 43.5 43.1 42.5 41.8 41.5 41 40.4
white (%) 90 91.5 90.9 90.4 89.9 89.5 88.6 88.1
HTN (%) 65.6 58.4 61.7 63.5 62.2 65.2 74.3 80.1
DM (%) 29.9 26 27.3 28.2 28.1 29 35.5 40.2
PVD (%) 4.9 4.3 4.7 4.5 4.7 4.7 5.2 6.6
Stroke/TIA (%) 4.2 4.4 4.2 3.9 3.7 4 4.7 5.6
HF (%) 23.4 22.3 22.3 22.4 22.6 21.3 26.2 29.9
renal failure (%) 10 3.6 4.5 5.4 12.2 10.5 17.6 24.5
acute MI (%) 29.9 26.9 27.5 26.1 25.9 30.8 37.6 45.8
elective (%) 43.1 39.1 41.5 45.3 47.4 40.1 40.2 47
post-procedure LOS
(days)
2 2 2 2 2 2 2 3
hospital mortality (%) 2.1 2.1 2 1.8 1.8 2.1 2.4 3.1
30 day mortality (%) 3.1 3 2.8 2.6 2.7 3.2 3.7 4.6
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terized by higher comorbidity burden and higher incidence of acute
MI. Hospital mortality increased signiﬁcantly over time, especially
for patients presenting electively. Following adjustment for wors-
ening baseline characteristics over time, adjusted hospital mortality
was 42% higher in 2012 compared to 2000, OR 1.42 (95% CI 1.36–
1.48).
CATEGORIES CORONARY: PCI Outcomes
KEYWORDS Coronary artery disease, Outcomes research, PCI -
Percutaneous Coronary Intervention
TCT-166
Angiographic and Long-term Clinical Outcomes after Bare-metal, First-
generation, and Second-generation Drug-eluting Stent Implantation for
Left Main Coronary Artery Disease: from the Japanese Left Main Coronary
Stenting Registry
Masanobu Ohya,1 Kazushige Kadota,1 Yasushi Fuku,1
Mamoru Toyofuku,2 Hirooki Higami,3 Kyohei Yamaji,4
Hiromi Muranishi,4 Yuhei Yamaji,4 Koji Nishida,5 Daisuke Furukawa,5
Tomohisa Tada,6 Euihong Ko,2 Kenji Ando,4 Hiroki Sakamoto,6
Takashi Tamura,2 Kazuya Kawai,5 Takeshi Kimura3
1Kurashiki Central Hospital, Kurashiki, Japan; 2Wakayama Medical
Center, Wakayama, Japan; 3Kyoto University Graduate School of
Medicine, Kyoto, Japan; 4Kokura Memorial Hospital, Kitakyushu,
Japan; 5Chikamori Hospital, Kochi, Japan; 6Shizuoka General Hospital,
Shizuoka, Japan
BACKGROUND We aimed to evaluate the angiographic and long-term
clinical outcomes after treatment for left main coronary artery disease
(LMCAD) with bare-metal stents (BMS), ﬁrst-generation, and second-
generation drug-eluting stents (G1-DES and G2-DES).
METHODS The Left Main Coronary Stenting Registry in Japan is a
multicenter registry enrolling 1800 consecutive patients with
LMCAD treated with stent implantation between 2004 and 2012: 355
patients with BMS, 875 with G1-DES, and 570 with G2-DES. The
clinical endpoints assessed included all-cause death, cardiac death,
sudden death, deﬁnite or probable stent thrombosis, and target-
lesion revascularization (TLR). We distinguished in-hospital death
from long-term clinical outcomes. The 6-year cumulative rates of
adverse events were estimated by Kaplan-Meier methods with p
values from log-rank tests. The angiographic endpoint was deﬁned
as in-stent restenosis within one year after procedure. In addition
to restenosis at stent-implanted site, restenosis at bifurcation
site was deﬁned as a percent diameter >50% within 5 mm from
the stent-implanted bifurcation lesion in both main and side
branches.
RESULTS The median follow-up duration was 3.9 years (the ﬁrst
and third quarters, 2.2 and 5.9 years). Among patients with BMS,
G1-DES, and G2-DES, there were no signiﬁcant differences in the
cumulative 6-year incidences of all-cause death (24.8% vs. 23.0%
vs. 23.8%, p¼0.48), cardiac death (8.3% vs. 10.2% vs. 5.4%,
p¼0.65), sudden death (2.4% vs. 3.7% vs. 2.0%, p¼0.95), and deﬁ-
nite or probable stent thrombosis (1.6% vs. 0.8% vs. 2.1%, p¼0.11),whereas patients with BMS had a signiﬁcantly higher cumulative
rate of TLR than those with G1- and G2-DES (26.6% vs. 15.4% vs.
10.4%, p<0.001). In this study sample, 1394 patients (77.4%) un-
derwent follow-up angiography within one year after the initial
procedure. The in-stent restenosis rate was signiﬁcantly higher in
patients with BMS than in those with 1st and 2nd DES (27.2% vs.
11.7% vs. 5.7%, p<0.001). The restenosis rate in the proximal left
main stem showed no signiﬁcant difference between patients with
G1- and G2-DES (3.2% vs. 2.4%, p¼0.48), whereas the main and side
bifurcation restenosis rates were signiﬁcantly higher in patients
with G1-DES than in those with G2-DES (5.0% vs. 2.4%, p¼0.04 and
5.3% vs. 1.3%, p<0.001).
CONCLUSIONS DES for LMCAD appeared to be associated with more
favorable outcomes of TLR than BMS. Although G2-DES improved the
in-stent restenosis rate compared with G1-DES, especially in both
main and side bifurcation lesions, long-term clinical outcomes after
stent implantation for LMCAD were comparable between G1- and G2-
DES.
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BACKGROUND Peripheral vascular interventions with drug eluting
balloons (DEB) have been demonstrated to be superior to balloon
angioplasty (BA) in short-term follow up (6 months). Long-term out-
comes remain uncertain and we therefore assessed the long-term
outcomes at or beyond 12 months in this meta-analysis.
METHODS PubMed, EBSCO and Ovid databases were searched to
identify randomized controlled trials (RCT) comparing drug-eluting
balloons with balloon angioplasty for the management of femo-
ropopliteal and or infrapopliteal vascular disease. Outcomes of
target lesion revascularization (TVR), patency rates, death and
amputations were compared between the two groups using random
effects models and risk ratio (RR) with 95% conﬁdence intervals
were calculated.
RESULTS A total of 9 RCT’s were identiﬁed and included 1058
patients. Of these, 585 and 473 patients were randomized to DEB
and BA groups, respectively. The risk of TLR was signiﬁcantly lower
in the DEB group at 12 months (RR 0.34, 95% CI 0.22 – 0.53,
p<0.01) and 24 months (RR 0.37, 95% CI 0.16 – 0.84, p¼0.02)
compared to BA group. The patency rates were higher with the use
of DEB (RR 1.64, 95% CI 1.44 – 1.86, p<0.01). The risk of death was
similar in both the groups (RR 1.23, 95% CI 0.65 – 2.34, p¼0.52).
There was a favorable trend towards decrease in amputations with
the use of DEB, however this ﬁnding was not statistically signiﬁcant
(RR 0.64, 95% CI 0.17 – 2.53, p¼0.54). Heterogeneity was very low
among the included studies as assessed by Cochrane Q statistic
(I2¼25%). Publication bias was assessed by means of funnel plot
and this was deemed to be minimal.
